Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial
| Autor: | Neil M O'Brien-Simpson, Trevor J. Kilpatrick, Lisa Taylor, Elizabeth McDonald, Litza Kiropoulos, Jennifer Threader, Tomas Kalincik, Anneke van der Walt, Leonid Churilov, Vanja Rozenblat, Tissa Wijeratne |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Multiple Sclerosis Active Comparator Medicine (miscellaneous) Anxiety law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Intervention (counseling) Sleep Initiation and Maintenance Disorders Adaptation Psychological medicine Humans Pharmacology (medical) Active listening Single-Blind Method 030212 general & internal medicine Depression (differential diagnoses) Fatigue lcsh:R5-920 Depressive Disorder Cognitive Behavioral Therapy business.industry Multiple sclerosis Australia Correction Social Support Cognition Resilience Psychological medicine.disease Psychotherapy Action (philosophy) Physical therapy Quality of Life lcsh:Medicine (General) business 030217 neurology & neurosurgery |
| Zdroj: | Trials Trials, Vol 21, Iss 1, Pp 1-1 (2020) |
| ISSN: | 1745-6215 |
| Popis: | Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression and anxiety, particularly in the early stages of diagnosis. There is evidence to suggest that cognitive behavioural therapy (CBT) is effective for the treatment of depression amongst individuals with MS; however, there is a paucity of tailored CBT interventions designed to be offered in the newly diagnosed period. This trial is the first to assess the effectiveness and cost-effectiveness of a tailored CBT intervention compared to a supportive listening (SL) intervention amongst individuals with MS who are depressed.ACTION-MS is a two-arm parallel group, assessor-blinded, active comparator, randomised controlled trial which will test whether a tailored CBT-based intervention compared to an SL intervention can reduce depression and related factors such as anxiety, fatigue, pain and sleep problems in those newly diagnosed with MS. Sixty participants who are within 5 years of having received a diagnosis of MS and scored within the mild to moderate range of depression on the Beck Depression Inventory (BDI-II) will be recruited from MS clinics located across three hospital sites in Melbourne, Australia. The primary outcome is depression severity using the BDI-II at post-assessment. Intervention satisfaction and acceptability will be assessed. A cost-effectiveness analysis will also be conducted. Data will be analysed on an intention-to-treat basis.There is a scarcity of psychological interventions for depression targeting the newly diagnosed period. However, interventions during this time point have the potential to have a major impact on the mental and physical wellbeing of those newly diagnosed with MS. The current trial will provide data on the effectiveness of a tailored CBT intervention for the treatment of depression in those newly diagnosed with MS. Findings will also provide effect size estimates that can be used to power a later-stage multi-centre trial of treatment efficacy, and will provide information on the mechanisms underlying any treatment effects and cost-effectiveness data for delivering this intervention in outpatient MS clinics.ISRCTN trials registry, ISRCTN63987586. Current controlled trials. Retrospectively registered on 20 October 2017. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink